Laurie K Mischley, ND PhD MPH studied naturopathic medicine (ND) at Bastyr University and epidemiology (MPH) and nutritional sciences (PhD) at the University of Washington. Her work is focused on identifying the nutritional requirements unique to individuals with neurodegenerative diseases. She has published on coenzyme Q10, lithium, and glutathione deficiency in Parkinson's Disease (PD). As a clinical researcher, she has worked with the FDA, NIH, and the Michael J. Fox Foundation to administer intranasal glutathione, (in)GSH, to individuals with PD. Drawing on expertise in radiology, epidemiology, nutrition, neurology, and naturopathic medicine, she is attempting to determine whether (in)GSH boosts brain glutathione and improves health. She has served on the Bastyr University Institutional Review Board since 2010 and regularly provides integrative medicine research mentorship to students. She founded the Social Purpose Corporation, NeurRx, developed an outcome measure to assess PD severity, www.PROPD.org, and is author of the book Natural Therapies for Parkinson's Disease. Dr. Mischley maintains a small clinical practice at Seattle Integrative Medicine focused on nutrition and neurological health. Dr. Michelle Sexton received her ND from Bastyr University and completed a postdoctoral fellowship at the University of Washington in the Departments of Pharmacology and Psychiatry and Behavioral Sciences. She is the Medical Research Director at the Center for the Study of Cannabis and Social Policy. Her NIH-funded pre-doctoral and postdoctoral research was on the topic of the pharmacology of cannabinoids and the role of the endocannabinoid system in neuroinflammation and neurodegeneration. Her postdoctoral project was investigating the potential role of cannabis use on endocannabinoids and inflammatory markers in patients with Multiple Sclerosis. Dr. Sexton serves as an editor and technical advisor for the American Herbal Pharmacopoeia Cannabis Monograph. Dr. Sexton has presented her research internationally and is published in peer-reviewed journals. Dr. Sexton's clinical practice, research and teaching focus includes treating clinical endocannabinoid deficiency and the medical use of cannabis across a range of conditions and age groups. She is a member of the International Cannabinoid Research Society, the International Association of Cannabinoid Medicine and the Society of Cannabis Clinicians. She maintains a small medical practice in San Diego, CA.